P
Paracel Explorer
Dernière publication·Octobre 2026

Optiray 300

Ioversolum — sol inj 300 mg/ml

Guerbet AG

ATCV08AB07
Swissmedic49999
Dossier15917
Remboursement
QP 10%
Modifications (33)